Add BrightSurf on Google Email

Child Health Day 2024: influenza vaccine protects children from infection and hospitalization for the disease, Spanish study shows

A Spanish study found that the influenza vaccination campaign for children aged 6-59 months was effective in preventing acute respiratory infections and hospitalization. The study estimated the vaccine to be 70% effective against any influenza type and 77% effective against severe cases.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeObservational study·DateOct 3, 2024

The Lancet Public Health: MMR vaccine remains the best protection against measles - modelling study in England suggests level of protection decreases slightly over time

A modelling study suggests that slow waning of MMR vaccine-induced immunity may contribute to rising measles cases in double-vaccinated people. However, the MMR vaccine remains the most effective measure to prevent measles infection, and community vaccination levels above 95% are essential to prevent outbreaks.

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateSep 26, 2024

New vaccine created by Mizzou researchers protects cattle from deadly tick-borne disease

A new vaccine created by Mizzou researchers protects cattle from bovine anaplasmosis, a devastating tick-borne disease causing hundreds of millions of dollars in economic losses. The vaccine has been proven to give immunized cattle protection for at least a month and is being discussed with industry partners for future distribution.

SourceUniversity of Missouri-Columbia·JournalVaccine·TypeExperimental study·DateAug 28, 2024

Smallpox vaccination in childhood could offer protection against monkeypox clade II viruses, study finds

A European study found that prior smallpox vaccination in childhood could offer protection against infections caused by monkeypox virus (MPXV) clade II in men. The estimated degree of protection varied among countries, highlighting the need for further research.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateAug 22, 2024

Comprehensive meta-analysis pinpoints what vaccination strategies different countries should adopt

A comprehensive meta-analysis found that interventions increasing access to vaccines and providing transportation assistance tripled vaccination odds, particularly in low-income countries. Financial incentives also showed a moderate effect, but were less impactful.

SourceAnnenberg Public Policy Center of the University of Pennsylvania·JournalNature Human Behaviour·TypeMeta-analysis·DateAug 1, 2024

New ECDC Director Pamela Rendi-Wagner emphasises importance of restoring and reinforcing public trust in science after pandemic, in editorial for Eurosurveillance

Dr. Pamela Rendi-Wagner, new ECDC Director, stresses the need to restore and reinforce public trust in science after the COVID-19 pandemic. She highlights challenges such as war, climate change, and social inequalities, which can lead to misinformation and reversed medical advances. ECDC is taking steps to implement its expanded mandat...

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeCommentary/editorial·DateJul 18, 2024

Social media use is associated with more frequent vaccination

Researchers found a consistent positive relation between social media use and vaccination across all major political parties. For Democrats, social media exposure predicted greater vaccine uptake due to increased information about new pathogens. For Republicans, believing others were vaccinated was the key factor.

SourceAnnenberg Public Policy Center of the University of Pennsylvania·JournalSocial Science & Medicine·TypeSurvey·DateJun 24, 2024

Reexamining misinformation: How unflagged, factual content drives vaccine hesitancy

A study by University of Pennsylvania researchers found that unflagged, factual content about COVID-19 vaccines is more damaging to public health than intentionally false or misleading information. Factual articles with sensational headlines and statistics can lower users' intentions to get vaccinated by 2.3 percentage points.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalScience·TypeData/statistical analysis·DateMay 30, 2024

APPC scholars find knowledge a factor in closing black-white COVID-19 vaccination gap

Research by APPC scholars found that increased knowledge about Covid-19 vaccination made a significant difference in reducing the disparity between Black and White Americans' vaccination rates. This increase was associated with improved trust in vaccine safety and efficacy, as well as reduced skepticism towards vaccines.

SourceAnnenberg Public Policy Center of the University of Pennsylvania·JournalJournal of Health Communication·TypeSurvey·DateMay 30, 2024

Association of new-onset seizures with SARS-CoV-2 vaccines

A systematic review and meta-analysis found no association between new-onset seizures and SARS-CoV-2 vaccination. The study included over 118,000 participants from randomized clinical trials and found the incidence proportion of new-onset seizures to be similar across vaccine recipients and unvaccinated participants.

SourceJAMA Network·JournalJAMA Neurology·DateApr 29, 2024

Future parents more likely to get RSV vaccine when pregnant if aware that RSV can be a serious illness in infants

A nationwide survey found that pregnant people are more likely to receive the RSV vaccine if they believe the virus can be a serious illness in infants. The study also shows that parents with an existing child at home are more likely to get vaccinated, highlighting the importance of awareness and education.

A new coating method in mRNA engineering points the way to advanced therapies

Researchers at Tokyo Medical and Dental University have developed a novel method for coating engineered messenger RNA molecules with polyethylene glycol (PEG), allowing selective delivery to the spleen. This breakthrough enables fine-tuned control over mRNA therapy, facilitating effective treatment of diseases previously considered inc...

SourceTokyo Medical and Dental University·JournalSmall Science·DateApr 10, 2024

Swedish study indicates a significant decline of neutralising antibodies to monkeypox virus already during the first month after vaccination

A Swedish study reveals that neutralising antibodies to the monkeypox virus decline significantly after two doses of the MVA-BN vaccine within the first month. The findings suggest that a booster dose may be necessary to maintain immunity, emphasizing the need for scientific evidence before policy decisions are made.

New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies

A new vaccine developed by UCLA researchers demonstrates high protection against melioidosis, a tropical disease that causes 89,000 fatalities annually. The vaccine was tested in mice and found effective even against a highly lethal strain of the bacteria.

SourceUniversity of California - Los Angeles Health Sciences·JournalmBio·TypeExperimental study·DateMar 21, 2024

U.S. could cut cervical cancer cases & deaths by up to 20% if more patients got follow-up after screening, study suggests

A new study suggests that removing barriers to cervical cancer screening, surveillance, and diagnostic procedures can save lives and reduce disparities. If every eligible person gets the full screening and follow-up tests recommended, up to 23% fewer people would be diagnosed with cervical cancer and 20% fewer would die from it.

SourceMichigan Medicine - University of Michigan·TypeData/statistical analysis·DateMar 19, 2024

Vac to the future

A competition among researchers predicted B. pertussis vaccine responses based on a simple correlation between calendar age and antibody responses. The result highlights the need for further research to understand variability in vaccination outcomes.

SourceLa Jolla Institute for Immunology·JournalCell Reports Methods·TypeData/statistical analysis·DateMar 14, 2024

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

A new study finds that the high burden of typhoid fever in sub-Saharan African countries calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines. The study estimates that there are 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths.

SourceInternational Vaccine Institute·JournalThe Lancet Global Health·TypeObservational study·DateMar 12, 2024

In fight against brain pathogens, the eyes have it

Researchers found that vaccines injected into mouse eyes can disable the herpes virus and activate an immune response through lymphatic vessels along the optic nerve. This discovery highlights a shared immune response between the brain and eyes, providing a potential new approach to combating ocular and central nervous system diseases.

SourceYale University·JournalNature·DateFeb 28, 2024

Five grand challenges for the future at the interface of engineering and medicine

Researchers identify five grand challenges in biomedical engineering to address social needs, existing gaps, and technological limitations. The Convergence Revolution and Fourth Industrial Revolution are expected to shape the future of medicine, emphasizing interdisciplinary collaborations and next-generation training.

SourceUniversity of Alabama at Birmingham·JournalIEEE Open Journal of Engineering in Medicine and Biology·TypeCommentary/editorial·DateFeb 26, 2024